MDWD
Price
$17.97
Change
-$0.00 (-0.00%)
Updated
Oct 16 closing price
26 days until earnings call
SYBX
Price
$1.44
Change
-$0.00 (-0.00%)
Updated
Oct 16 closing price
Ad is loading...

MDWD vs SYBX

Header iconMDWD vs SYBX Comparison
Open Charts MDWD vs SYBXBanner chart's image
MediWound
Price$17.97
Change-$0.00 (-0.00%)
Volume$59.25K
CapitalizationN/A
Synlogic
Price$1.44
Change-$0.00 (-0.00%)
Volume$3.91K
CapitalizationN/A
View a ticker or compare two or three
MDWD vs SYBX Comparison Chart
Loading...
MDWD
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
SYBX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
MDWD vs. SYBX commentary
Oct 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MDWD is a Buy and SYBX is a Sell.

COMPARISON
Comparison
Oct 18, 2024
Stock price -- (MDWD: $18.11 vs. SYBX: $1.42)
Brand notoriety: MDWD and SYBX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MDWD: 74% vs. SYBX: 102%
Market capitalization -- MDWD: $194.8M vs. SYBX: $17.9M
MDWD [@Biotechnology] is valued at $194.8M. SYBX’s [@Biotechnology] market capitalization is $17.9M. The market cap for tickers in the [@Biotechnology] industry ranges from $531.34B to $0. The average market capitalization across the [@Biotechnology] industry is $2.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MDWD’s FA Score shows that 1 FA rating(s) are green whileSYBX’s FA Score has 1 green FA rating(s).

  • MDWD’s FA Score: 1 green, 4 red.
  • SYBX’s FA Score: 1 green, 4 red.
According to our system of comparison, MDWD is a better buy in the long-term than SYBX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MDWD’s TA Score shows that 4 TA indicator(s) are bullish while SYBX’s TA Score has 3 bullish TA indicator(s).

  • MDWD’s TA Score: 4 bullish, 3 bearish.
  • SYBX’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, MDWD is a better buy in the short-term than SYBX.

Price Growth

MDWD (@Biotechnology) experienced а +8.12% price change this week, while SYBX (@Biotechnology) price change was -0.70% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.91%. For the same industry, the average monthly price growth was +2.47%, and the average quarterly price growth was -6.27%.

Reported Earning Dates

MDWD is expected to report earnings on Mar 13, 2025.

SYBX is expected to report earnings on Nov 09, 2023.

Industries' Descriptions

@Biotechnology (+0.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MDWD($195M) has a higher market cap than SYBX($17.9M). MDWD YTD gains are higher at: 76.696 vs. SYBX (-62.597). MDWD has higher annual earnings (EBITDA): -4.54M vs. SYBX (-54.96M). MDWD has more cash in the bank: 29.2M vs. SYBX (20M). SYBX has less debt than MDWD: SYBX (0) vs MDWD (6.36M). MDWD has higher revenues than SYBX: MDWD (20.1M) vs SYBX (3.17M).
MDWDSYBXMDWD / SYBX
Capitalization195M17.9M1,089%
EBITDA-4.54M-54.96M8%
Gain YTD76.696-62.597-123%
P/E RatioN/AN/A-
Revenue20.1M3.17M634%
Total Cash29.2M20M146%
Total Debt6.36M0-
FUNDAMENTALS RATINGS
MDWD vs SYBX: Fundamental Ratings
MDWD
SYBX
OUTLOOK RATING
1..100
1277
VALUATION
overvalued / fair valued / undervalued
1..100
75
Overvalued
21
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9899
PRICE GROWTH RATING
1..100
5064
P/E GROWTH RATING
1..100
5100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SYBX's Valuation (21) in the Biotechnology industry is somewhat better than the same rating for MDWD (75) in the Pharmaceuticals Other industry. This means that SYBX’s stock grew somewhat faster than MDWD’s over the last 12 months.

SYBX's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as MDWD (100) in the Pharmaceuticals Other industry. This means that SYBX’s stock grew similarly to MDWD’s over the last 12 months.

MDWD's SMR Rating (98) in the Pharmaceuticals Other industry is in the same range as SYBX (99) in the Biotechnology industry. This means that MDWD’s stock grew similarly to SYBX’s over the last 12 months.

MDWD's Price Growth Rating (50) in the Pharmaceuticals Other industry is in the same range as SYBX (64) in the Biotechnology industry. This means that MDWD’s stock grew similarly to SYBX’s over the last 12 months.

MDWD's P/E Growth Rating (5) in the Pharmaceuticals Other industry is significantly better than the same rating for SYBX (100) in the Biotechnology industry. This means that MDWD’s stock grew significantly faster than SYBX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MDWDSYBX
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
87%
Momentum
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
79%
Bullish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 4 days ago
78%
Bullish Trend 2 days ago
84%
Declines
ODDS (%)
Bearish Trend 10 days ago
81%
Bearish Trend 7 days ago
87%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
86%
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Ad is loading...
MDWD
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
SYBX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME21.660.39
+1.83%
GameStop Corp
BTC.X67612.720000571.609400
+0.85%
Bitcoin cryptocurrency
TSLA221.331.76
+0.80%
Tesla
SPY582.302.52
+0.43%
SPDR® S&P 500® ETF Trust
AAPL231.78-2.07
-0.89%
Apple

MDWD and

Correlation & Price change

A.I.dvisor indicates that over the last year, MDWD has been loosely correlated with PHIO. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if MDWD jumps, then PHIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MDWD
1D Price
Change %
MDWD100%
+5.21%
PHIO - MDWD
35%
Loosely correlated
+17.75%
AKRO - MDWD
33%
Poorly correlated
+3.74%
KALA - MDWD
26%
Poorly correlated
+1.15%
SYBX - MDWD
26%
Poorly correlated
+2.13%
BYSI - MDWD
25%
Poorly correlated
-4.02%
More

SYBX and

Correlation & Price change

A.I.dvisor indicates that over the last year, SYBX has been loosely correlated with BNOX. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if SYBX jumps, then BNOX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SYBX
1D Price
Change %
SYBX100%
+2.13%
BNOX - SYBX
64%
Loosely correlated
+3.37%
VCNX - SYBX
38%
Loosely correlated
+7.66%
SBHMY - SYBX
38%
Loosely correlated
N/A
BTAI - SYBX
34%
Loosely correlated
+1.95%
GRTS - SYBX
31%
Poorly correlated
-12.54%
More